NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

Rentabilité sur six mois: -20.96%
Secteur: Healthcare

Calendrier des promotions Sensei Biotherapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

plus de détails
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

EBITDA -0.0124
EV/EBITDA -1.28
IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
P/BV 1
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 1.04
Число акций ао 0.02795 млрд
Changement de prix par jour: +3.92% (0.4792)
Changement de prix par semaine: +10.69% (0.4499)
Changement de prix par mois: -10.35% (0.5555)
Changement de prix sur 3 mois: -10.35% (0.5555)
Changement de prix sur six mois: -20.96% (0.6301)
Changement de prix par an: -28.03% (0.692)
Evolution du prix sur 3 ans: -91.31% (5.73)
Evolution du prix sur 5 ans: 0% (0.498)
Evolution des prix sur 10 ans: 0% (0.498)
Evolution des prix depuis le début de l'année: +9.67% (0.4541)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
Total: 3.75

Efficacité

Nom Signification Grade
ROA, % -45.85 0
ROE, % -52.55 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.1701 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 0 0
Rentabilité Ebitda, % 169.24 10
Rentabilité EPS, % -20.78 0
Total: 5.6
Plus de détails

Établissements Volume Partager, %
Newtyn Management, LLC 1572023 6.27
Vanguard Group Inc 573651 2.29
Renaissance Technologies, LLC 143508 0.57
Geode Capital Management, LLC 136318 0.54
Bridgeway Capital Management, Inc. 112900 0.45
Duquesne Family Office LLC 100000 0.4
Bank of America Corporation 90788 0.36
Millennium Management LLC 38295 0.15
Blackrock Inc. 34813 0.14
Northern Trust Corporation 26049 0.1



Superviseur Titre d'emploi Paiement Année de naissance
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 année)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 année)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 années)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

Adresse: United States, Rockville. MD, 1405 Research Boulevard - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.senseibio.com